A genetic disease-focused pharmaceutical company is seeking novel therapeutic targets for genetic mitochondrial diseases and leukodystrophies. The team is also interested in innovative drug discovery and development platforms tailored to these disease areas. Approaches of Interest: <ul> <li>Submission for mitochondrial diseases should focus on: (i) Target molecules expressed in brain cells (neurons, microglia, astrocytes, oligodendrocytes) (ii) Mechanisms that improve oxygen consumption, NAD&#x207A;/NADH ratio, or overall mitochondrial function (other MoAs will be considered...</li></ul>

A genetic disease-focused pharmaceutical company is seeking novel therapeutic targets for genetic mitochondrial diseases or leukodystrophies. There is also interest in innovative drug discovery and development platforms tailored to these diseases.

Innovative Therapies for Genetic Mitochondrial Disorders and Leukodystrophy

Opportunity types being sought:

To see the full details and submit your response please register now.

Benefits of registration:

Opportunity types being sought: